A New Approach to Drug Therapy in Non-alcoholic Steatohepatitis (NASH)

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.31, Iss.6, 2003-11, pp. : 537-551

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis

By Fisher Craig

Archives of Toxicology, Vol. 82, Iss. 12, 2008-12 ,pp. : 959-964

Springer Publishing Company

Access to resources Recommend Favorite

Non-Alcoholic Steatohepatitis: New Insights from OMICS Studies

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 5, 2012-04 ,pp. : 726-735

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for non-alcoholic steatohepatitis

By Tomeno Wataru Yoneda Masato Imajo Kento Ogawa Yuji Kessoku Takaomi Saito Satoru Eguchi Yuichiro Nakajima Atsushi

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 3, 2013-09 ,pp. : 279-290

Informa Healthcare

Access to resources Recommend Favorite

Evolving therapies for non-alcoholic steatohepatitis

By Tilg Herbert Moschen Alexander R

Expert Opinion on Drug Discovery, Vol. 9, Iss. 6, 2014-06 ,pp. : 687-696

Informa Healthcare

Access to resources Recommend Favorite

Cyclophosphamide/dexamethasone: Non-alcoholic steatohepatitis: case report

Reactions Weekly, Vol. 1, Iss. 1233, 2009-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite